The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials?

Am J Respir Crit Care Med. 2022 Apr 15;205(8):867-869. doi: 10.1164/rccm.202201-0018ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Idiopathic Pulmonary Fibrosis* / drug therapy
  • Pyridones

Substances

  • Pyridones